Navigation Links
Sphere Fluidics Successfully Closes a $2.5 million Series A Investment Round
Date:2/20/2013

CAMBRIDGE, England, February 20, 2013 /PRNewswire/ --

Sphere Fluidics, an early-stage, Cambridge-based company focusing on developing novel products and services for single cell analysis, has just completed a $2.5 million investment round. The investment syndicate was led by 24Haymarket and included the Royal Society, Cambridge Enterprise Limited, Providence Investment Company Limited, University of Cambridge Enterprise Fund, the London Business Angels Roundtable EIS Fund and a number of individual angels from London (including members of the London Business Angels) and Cambridge.

Sphere Fluidics Limited is a growing Life Sciences company, based on technology originating from the Chemistry Department of Cambridge University. The Company has now fully developed this technology into a novel platform for single cell analysis and characterisation that enables the discovery and development of new biopharmaceuticals and cell therapies and novel ways to study single cell diseases, such as cancer. Sphere Fluidics has patented novel biochip systems that automatically process millions of miniaturised (picolitre to nanolitre) tests in picodroplets enabling the discovery of the one in a million cells or molecules that could be the next pharmaceutical industry "blockbuster".

Andrew Mackintosh ,  Chairman of Sphere Fluidics and Chief Executive of the Royal Society Enterprise Fund, comments: "Sphere Fluidics is exactly the sort of early-stage, high-potential company that the Royal Society Enterprise Fund was set up to support.  The business is an outstanding example of the successful translation of excellent science into commercial potential.  I am delighted that such a strong network of business angels is supporting the company, bringing not only funding but extensive business experience and contacts.

Ian Gray , a member of 24Haymarket and a new Company Director of Sphere Fluidics, says "24Haymarket are delighted to participate in the next phase of the Company's growth. This growth will be based on the foundations of world-class science and strong focused management, and will result from sales to and collaborations with innovative forward thinking customers and contacts."

Frank Craig , Sphere Fluidics' CEO, comments, "We are very pleased to close this round as it gives us the resources to further develop our business. There was strong interest in the company and we were pleased to welcome 24Haymarket into an impressive syndicate of investors. I am excited about further applying our exciting technology to major Life Sciences markets and accelerating its commercialisation".

Press Contact
Sphere Fluidics Limited. Contact Dr Frank Craig on:
E-mail: Frank.Craig@spherefluidics.com
Tel: + 44 (0)1223-389004.


'/>"/>
SOURCE Sphere Fluidics Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CryoLife Completes Acquisition of Hemosphere
2. PhytoSPHERE Systems, a Medical Marijuana Inc Portfolio Company, to Bring Production Facilities to Europe through Canipa Holdings.
3. Medical Marijuana Inc.s Subsidiary, PhytoSPHERE Systems, Signs the Largest Production Contract in Company History Valued at $7.5 Million
4. Presentation of Possible "Fountain of Youth" Pill Creating "Celebrity" Atmosphere at San Antonio Scientific Conference
5. Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems, LLC Cites Broad Applications of its 2013 Harvest of Uniquely Valuable Hemp Oil
6. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
9. Columbia Asia Referral Hospital, Yeshwanthpur, Successfully Conducts HOLEP to Treat a 72-Year-old With Urology Disorder
10. Independa Closes Convertible Note Funding at $2.35 Million
11. Stereotaxis Closes $18.5 Million Private Placement Financings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... Mich. , May 31, 2016  Diplomat Pharmacy, Inc. ... pharmacy, has announced that Phil Hagerman , Chairman & ... the upcoming William Blair 36 th Annual Growth Stock ... Mr. Hagerman and Mr. Whelan are scheduled to present at ... Central Time. A live audio-only webcast of the presentation and ...
(Date:5/31/2016)... , May 31, 2016 ... ingredient in food, cosmetics and pharmaceuticals, with global volume ... worth US$ 1.6 Bn. Demand for aloe ... juices, and yogurts will continue its upward momentum in ... will also boost positive sentiment on aloe vera, with ...
(Date:5/31/2016)... , Isansys  Lifecare, a new generation digital healthcare ... wireless patient monitoring platform, as it ships more systems to hospitals ... Scotland and Norway ... launched earlier this year, is now being used in ground-breaking ... new technology significantly enhances the user experience and provides ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... May 31, 2016 , ... ... mix of advanced Artificial Intelligence (AI) and the latest in Clinical Patient ... center is integrating predictive analytic outputs directly into the clinical workflow. These insights ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... diagnostics device that enables unprecedented portability and convenience. , The Cube is exceptionally ... cubed in size, the Cube fits easily into any space, whether in a ...
(Date:5/31/2016)... , ... May 31, 2016 , ... The Global ... today released ten predictions on the future of wellness, travel, spa and beauty in ... travel, spa and beauty companies to leading economists and researchers - to forecast where ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... The Orthopaedic ... executive committee members: , David G. Lewallen, MD, began his term as president ... president. Michael L. Parks, MD, is OREF’s new president-elect. Richard F. Kyle, MD, will ...
(Date:5/31/2016)... ... ... a recent interview on The Greenburgh Report radio show hosted by Greenburgh, NY Town ... leading medical insurance advocate Adria Goldman Gross discussed several eye-opening issues that have combined ... the interview with Mr. Feiner that aired on May 7, 2016, Ms. Gross, the ...
Breaking Medicine News(10 mins):